The effect of electroacupuncture in Parkinson's disease

Assess the efficacy of Electroacupuncture vs. Sham Acupuncture on Gait in patients with Parkinson's Disease

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170305032893N4

Enrollment

Registered

2023-05-02

Start date

2023-04-09

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PARKINSON. Parkinson's disease

Interventions

Intervention 1: Intervention group: Acupuncturist will perform acupuncture at predetermined and identical points for all participants in this group. And then the electrodes of the electroacupuncture d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Men/Women with parkinson diagnosis- walk for at least 10 meters without help-disease stable condition and no need to change dosage for two months-able to fillout consent form- no history of tratment of acupuncture fixed classic medicine regime treatment-parkinson with movment disorder- Hohen$Yar scale 1 to4

Exclusion criteria

Exclusion criteria: Gait disorder other than parkinson Life-threatening conditions, mental disorder, alcohol /drug abuse Electrical device/skin diseases interfere with electroacupuncture Change of drug dose /type for any reason during the study period Belonephobia Coagulation disorder and anticoagulant use Failure to cooperate in intervention for more than two sessions Pregnancy Patients with cardiac arrhythmia History of dementia or stroke History of cognitive disorders History of postural hypotension Neurological diseases such as Huntington's disease/MS, ALS History of epilepsy Acupuncture intolerance Having DBS(deep brain stimulation)

Design outcomes

Primary

Measure	Time frame
The primary outcome includes the measurement of gait parameters :single support time , double support time , swing time , velocity , cadence ,stride length , stride time. Timepoint: Start of study, fourth week,twelfth week. Method of measurement: Video recording of walking and data analysis.	—

Secondary

Measure	Time frame
Sleep problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.;Constipation problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.;Fatigue based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.	—

Measure

Time frame

Sleep problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.;Constipation problems based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.;Fatigue based on the MDS-UPDRSI questionnaire. Timepoint: At the beginning of the study and week 4 and week 12. Method of measurement: questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Asadzadeh

Mashhad University of Medical Sciences

asadzadehb991@mums.ac.ir+98 51 3855 2189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026